MRK 全部观点

已加载 3 条观点条目,其中 0 条方向发生变化

在已加载记录中筛选
Schwab Network发布 2026-10-15
《The Big 3: MRK, GILD, XOM》
$MRK看涨
AI 摘要 · MRK 正扭转一个半月的下跌趋势,并在自约 157 回落之后突破下降通道;RSI 动能转向上行,长期牛旗形态指向约 170,下月可能突破至 165-170 的新历史高点。并非必然;风险仍存;财报即将公布。

Merck是你的首选,而且今天确实跑赢了大盘。它的股价上涨了2%。他们本月底将发布财报。这里我对Merck印象深刻,因为它已经开始扭转过去一个半月左右所处的下跌趋势。看起来我们今天可能正在突破那个下行通道,听听Ben的看法会很有意思,但我认为,既然该公司已经找到了一些稳定性,现在有可能看到更高的价格走势。

Merck is your first choice and truly outperforms the market today. Its stock is up by 2%. They have an earnings announcement due at the end of this month. I am impressed with " Merck" here because it has started to reverse the downward trend it has been in for the past month and a half or so .

It looks like we may be breaking out of that down channel today, and it will be interesting to hear Ben's opinion , but I think there is a possibility of seeing higher price action now that the company has found some stability.

David Lin 发布 2026-09-27
《‘Almost 0%’ Chance Stocks Are Higher In 10 Years | Bill Smead》
$MRK看涨
AI 摘要 · MRK是一项持仓,其保守的会计处理(研发费用化)表明其真实盈利能力更高。

我们持有 Merc 和 Amgen,我们喜欢这两家公司,因为它们的会计处理是所有大型公司中最保守的。我这话是什么意思?它们每年把收入的 18% 到 20% 投入研发,并在当期一次性计入费用。

计入费用。它们不做折旧摊销。这是它们所做的最重要的长期投资。所以,它们的利润表实际上比其他公司要赚钱得多,因为它们的会计处理如此保守。

we own Merc and Amgen, and we love those companies because they have the most conservative accounting of any major corporations. What do I mean by that? They spend 18 to 20% of of their revenue each year on R&D and expense it upfront.

Expense it. They don't depreciate. It's the most important long-term investment they make. So, their income statement, they are actually much more profitable as compared to other corporations because of how conservative their accounting is.

Schwab Network发布 2026-09-09
《The Big 3: ROST, MRK, AAPL》
$MRK看跌
AI 摘要 · Merck 当前的强势被视为一项负担;预计将出现下行,并通过约 100 天后到期的看跌价差为此布局。

另一只大幅上涨的是 Merc,这是你在这里三大标的中的第二个选择。他们公布了非常积极的试验消息,也许离治愈黑色素瘤,或者至少对它有一种深度治疗,又近了一步。但正在失去、维持不住动能。

它们上涨约 14%,但从那些高点回落。你怎么看 Merc?

Uh another one with a big runup is Merc, which is your second pick here in the big three. They came out with a really positive trial news. perhaps were one step closer uh to curing melanoma or having at least a profound treatment for it.

Uh but losing, you know, maintaining their momentum. They're up about 14% but falling off of those highs. How are you looking at Merc?

他说在等
跌破145.62处的21日EMA或三角形的下趋势线
价格收于这些技术位下方
近期数个交易日图表技术面
削弱看涨的相对强度叙事,并支持看跌论点
已经是最早的记录
其他股票的全部观点条目
把 $MRK 加入我的股票30 天完整试用
开始试用